PK Interaction Between Rifapentine or Rifampicin and a Single Dose of TMC207 in Healthy Subjects (TMC207-CL002)
Clinical trial NCT02216331 · COMPLETED
Trial details
- NCT number
- NCT02216331
- Sponsor
- Global Alliance for TB Drug Development
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2010-05-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.